Cargando…

Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

Detalles Bibliográficos
Autores principales: Locatelli, Franco, Zugmaier, Gerhard, Mergen, Noemi, Bader, Peter, Jeha, Sima, Schlegel, Paul-Gerhardt, Bourquin, Jean-Pierre, Handgretinger, Rupert, Brethon, Benoit, Rossig, Claudia, Chen-Santel, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551174/
https://www.ncbi.nlm.nih.gov/pubmed/34707083
http://dx.doi.org/10.1038/s41408-021-00567-4
_version_ 1784591098584236032
author Locatelli, Franco
Zugmaier, Gerhard
Mergen, Noemi
Bader, Peter
Jeha, Sima
Schlegel, Paul-Gerhardt
Bourquin, Jean-Pierre
Handgretinger, Rupert
Brethon, Benoit
Rossig, Claudia
Chen-Santel, Christiane
author_facet Locatelli, Franco
Zugmaier, Gerhard
Mergen, Noemi
Bader, Peter
Jeha, Sima
Schlegel, Paul-Gerhardt
Bourquin, Jean-Pierre
Handgretinger, Rupert
Brethon, Benoit
Rossig, Claudia
Chen-Santel, Christiane
author_sort Locatelli, Franco
collection PubMed
description
format Online
Article
Text
id pubmed-8551174
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85511742021-10-29 Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study Locatelli, Franco Zugmaier, Gerhard Mergen, Noemi Bader, Peter Jeha, Sima Schlegel, Paul-Gerhardt Bourquin, Jean-Pierre Handgretinger, Rupert Brethon, Benoit Rossig, Claudia Chen-Santel, Christiane Blood Cancer J Author Correction Nature Publishing Group UK 2021-10-27 /pmc/articles/PMC8551174/ /pubmed/34707083 http://dx.doi.org/10.1038/s41408-021-00567-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Locatelli, Franco
Zugmaier, Gerhard
Mergen, Noemi
Bader, Peter
Jeha, Sima
Schlegel, Paul-Gerhardt
Bourquin, Jean-Pierre
Handgretinger, Rupert
Brethon, Benoit
Rossig, Claudia
Chen-Santel, Christiane
Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
title Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
title_full Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
title_fullStr Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
title_full_unstemmed Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
title_short Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
title_sort correction: blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the rialto trial, an expanded access study
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551174/
https://www.ncbi.nlm.nih.gov/pubmed/34707083
http://dx.doi.org/10.1038/s41408-021-00567-4
work_keys_str_mv AT locatellifranco correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT zugmaiergerhard correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT mergennoemi correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT baderpeter correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT jehasima correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT schlegelpaulgerhardt correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT bourquinjeanpierre correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT handgretingerrupert correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT brethonbenoit correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT rossigclaudia correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy
AT chensantelchristiane correctionblinatumomabinpediatricpatientswithrelapsedrefractoryacutelymphoblasticleukemiaresultsoftherialtotrialanexpandedaccessstudy